与墨西哥哈利斯科州COVID-19住院成年患者死亡率相关的流行病学因素

Q4 Medicine Medicina Interna de Mexico Pub Date : 2021-06-03 DOI:10.24245/mim.v37i3.5107
C. A. Andrade-Castellanos, L. Colunga-Lozano
{"title":"与墨西哥哈利斯科州COVID-19住院成年患者死亡率相关的流行病学因素","authors":"C. A. Andrade-Castellanos, L. Colunga-Lozano","doi":"10.24245/mim.v37i3.5107","DOIUrl":null,"url":null,"abstract":"BACKGROUND: The SARS-CoV-2 outbreak is a significant challenge to the healthcare system in Mexico;some regions are already struggling to fight the virus. OBJECTIVE: To identify comorbidities of adult patients with COVID-19 treated in hospitals in Jalisco and to assess their associations with the risk of death. MATERIALS AND METHODS: An observational, analytical, retrospective study in which we obtained data of confirmed COVID-19 cases and their characteristics from epidemiological surveillance system of the Mexican Health Secretary through Feb 27, 2020 to November 30, 2020. RESULTS: We included 5590 patients with a mean age of 58 years, 62% were men;overall mortality was 38%. The most common concomitant conditions were hypertension, diabetes and obesity. The multivariate analysis found that chronic kidney disease (OR = 2.71), obesity (OR = 1.24), chronic obstructive pulmonary disease (OR = 1.21), diabetes mellitus (OR = 1.15) and hypertension (OR = 1.13) were independent risk factors associated with mortality. CONCLUSIONS: The risk of dying was clearly higher in individuals with comorbidities, particularly among people with chronic kidney disease or obesity.","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epidemiologic factors associated with mortality among hospitalized adult patients with COVID-19 in the state of Jalisco, Mexico\",\"authors\":\"C. A. Andrade-Castellanos, L. Colunga-Lozano\",\"doi\":\"10.24245/mim.v37i3.5107\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND: The SARS-CoV-2 outbreak is a significant challenge to the healthcare system in Mexico;some regions are already struggling to fight the virus. OBJECTIVE: To identify comorbidities of adult patients with COVID-19 treated in hospitals in Jalisco and to assess their associations with the risk of death. MATERIALS AND METHODS: An observational, analytical, retrospective study in which we obtained data of confirmed COVID-19 cases and their characteristics from epidemiological surveillance system of the Mexican Health Secretary through Feb 27, 2020 to November 30, 2020. RESULTS: We included 5590 patients with a mean age of 58 years, 62% were men;overall mortality was 38%. The most common concomitant conditions were hypertension, diabetes and obesity. The multivariate analysis found that chronic kidney disease (OR = 2.71), obesity (OR = 1.24), chronic obstructive pulmonary disease (OR = 1.21), diabetes mellitus (OR = 1.15) and hypertension (OR = 1.13) were independent risk factors associated with mortality. CONCLUSIONS: The risk of dying was clearly higher in individuals with comorbidities, particularly among people with chronic kidney disease or obesity.\",\"PeriodicalId\":35750,\"journal\":{\"name\":\"Medicina Interna de Mexico\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicina Interna de Mexico\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24245/mim.v37i3.5107\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Interna de Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24245/mim.v37i3.5107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

背景:SARS-CoV-2疫情对墨西哥的卫生保健系统构成重大挑战;一些地区已经在努力抗击该病毒。目的:确定哈利斯科州医院治疗的成年COVID-19患者的合并症,并评估其与死亡风险的关系。材料和方法:一项观察性、分析性、回顾性研究,从墨西哥卫生部长的流行病学监测系统中获取2020年2月27日至2020年11月30日的COVID-19确诊病例及其特征数据。结果:我们纳入5590例患者,平均年龄58岁,62%为男性,总死亡率为38%。最常见的伴随疾病是高血压、糖尿病和肥胖。多因素分析发现,慢性肾脏疾病(OR = 2.71)、肥胖(OR = 1.24)、慢性阻塞性肺疾病(OR = 1.21)、糖尿病(OR = 1.15)和高血压(OR = 1.13)是与死亡相关的独立危险因素。结论:有合并症的患者死亡风险明显更高,特别是慢性肾脏疾病或肥胖患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Epidemiologic factors associated with mortality among hospitalized adult patients with COVID-19 in the state of Jalisco, Mexico
BACKGROUND: The SARS-CoV-2 outbreak is a significant challenge to the healthcare system in Mexico;some regions are already struggling to fight the virus. OBJECTIVE: To identify comorbidities of adult patients with COVID-19 treated in hospitals in Jalisco and to assess their associations with the risk of death. MATERIALS AND METHODS: An observational, analytical, retrospective study in which we obtained data of confirmed COVID-19 cases and their characteristics from epidemiological surveillance system of the Mexican Health Secretary through Feb 27, 2020 to November 30, 2020. RESULTS: We included 5590 patients with a mean age of 58 years, 62% were men;overall mortality was 38%. The most common concomitant conditions were hypertension, diabetes and obesity. The multivariate analysis found that chronic kidney disease (OR = 2.71), obesity (OR = 1.24), chronic obstructive pulmonary disease (OR = 1.21), diabetes mellitus (OR = 1.15) and hypertension (OR = 1.13) were independent risk factors associated with mortality. CONCLUSIONS: The risk of dying was clearly higher in individuals with comorbidities, particularly among people with chronic kidney disease or obesity.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medicina Interna de Mexico
Medicina Interna de Mexico Medicine-Internal Medicine
CiteScore
0.30
自引率
0.00%
发文量
137
期刊介绍: La revista Medicina Interna de México es el órgano oficial del Colegio de Medicina Interna de México Reserva de Titulo de la Dirección General del Derecho de Autor (SEP) número 04-2001-112110545900.-102 certificado de Licitud de Titulo número 11967 y Certilicado de Licitud de Contenido de la Comisión Catificadora de Publicaciones y Revistas Ilustradas (SeGob) número 8375. AutorIzada por SEPOMEX como Publicación Penódica Registro número PPO9- 0884
期刊最新文献
The evolution of pharmacological treatment of COVID-19 COVID-19, that global parenthesis Cardiovascular, hematological and renal implications of COVID-19 Acute kidney injury as a predictor of hospital discharge in COVID-19 patients Telogen effluvium and alopecia areata: Associated symptoms in patients with long COVID-19
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1